Body

New study involving CU-Boulder tells the tale of a kangaroo's tail

Kangaroos may be nature's best hoppers. But when they are grazing on all fours, which is most of the time, their tail becomes a powerful fifth leg, says a new study.

Involving researchers at the University of Colorado Boulder, Simon Fraser University in Burnaby, Canada, and the University of New South Wales in Sydney, Australia, the study illuminates the seemingly mundane task of foraging by red kangaroos. While such activity appears awkward, it turns out their tails provide as much propulsive force as their front and hind legs combined as they eat their way across the landscape.

Predicting the outcome of hepatitis C virus treatment

Millions of people throughout the world are infected with hepatitis C virus (HCV), which can lead to cirrhosis of the liver and cancer. Directly acting antiviral agents inhibit viral proteins and have been used to successfully treat HCV. Unfortunately, antiviral therapy fails in some patients, resulting in a relapse of HCV. A study published in the Journal of Clinical Investigation identifies a marker that can identify patients likely to have an HCV relapse after antiviral therapy.

New NIST metamaterial gives light a one-way ticket

The light-warping structures known as metamaterials have a new trick in their ever-expanding repertoire. Researchers at the National Institute of Standards and Technology (NIST) have built a silver, glass and chromium nanostructure that can all but stop visible light cold in one direction while giving it a pass in the other.* The device could someday play a role in optical information processing and in novel biosensing devices.

Fear, not data, motivates sunscreen users, research shows

BUFFALO, N.Y. – We're often told that worrying can be harmful to one's health. But University at Buffalo researchers say that when it comes to preventing skin cancer, a little fear is good for you.

In a study published in the Journal of Behavioral Medicine, the UB researchers found that fear and worry about skin cancer had a bigger influence on people's use of sunscreen than information about the statistical likelihood of developing the disease.

Biomarker predicts effectiveness of brain cancer treatment

Researchers at the University of California, San Diego School of Medicine have identified a new biomarker that predicts whether glioblastoma – the most common form of primary brain cancer – will respond to chemotherapy. The findings are published in the July print issue of Oncotarget.

Drug everolimus does not improve overall survival in patients with advanced liver cancer

Despite strong preclinical data, the drug everolimus failed to improve overall survival in patients with advanced liver cancer, compared to placebo, according to a study in the July 2 issue of JAMA.

Medicare-backed breast cancer screenings skyrocket, but do patients benefit?

Breast cancer screening costs for Medicare patients skyrocketed between 2001 and 2009, but the increase did not lead to earlier detection of new breast cancer cases, according to a study published by Yale School of Medicine researchers in the July 1 Journal of the National Cancer Institute.

Millions in need of HIV services will continue to be left out

This news release is available in Spanish and French.

Millions of people in need would benefit from HIV services in developing countries that are moving towards universal health coverage if these services were run more efficiently and integrated better into their health systems.

Poor physical, financial health driven by same factors

Poor physical health and financial health are driven by the same underlying psychological factors, finds a new study out of the Olin Business School at Washington University in St. Louis.

Researchers Lamar Pierce, PhD, associate professor of strategy at Olin and PhD-candidate Timothy Gubler found that the decision to contribute to a 401(k) retirement plan predicted whether or not an individual will act to correct poor physical health indicators revealed during an employer-sponsored health examination.

Behind a marine creature's bright green fluorescent glow

Pushing closer to understanding the mechanisms behind the mysterious glow of light produced naturally by certain animals, scientists at Scripps Institution of Oceanography at UC San Diego have deciphered the structural components related to fluorescence brightness in a primitive sea creature.

Engaging parents, community to map student success in South King County

If we had a road map to what parental involvement in schools should be, what would it look like? Would it be a straight line, or a complicated maze of cross streets going in every direction?

For cancer patients, sugar-coated cells are deadly

ITHACA, N.Y. – Every living cell's surface has a protein-embedded membrane that's covered in polysaccharide chains – a literal sugar coating. A new study by a Cornell University researcher found this coating is especially thick and pronounced on cancer cells and is a crucial determinant of the cell's survival.

Consisting of long, sugar-decorated molecules called glycoproteins, the coating causes physical changes in the cell membrane that make the cell better able to thrive – leading to a more lethal cancer.

Genetic evidence that body mass increases the risk of asthma in mid-childhood

Some of the increase in asthma risk toward the end of the 20th century could be attributed to the increase in body mass index (BMI) in mid-childhood, according to new research published in this week's PLOS Medicine. The study, led by Raquel Granell from the University of Bristol, UK, and colleagues, provides genetic evidence that higher fat mass and lean mass increase the risk of asthma in mid-childhood.

New compound blocks 'gatekeeper' enzyme to kill malaria

Melbourne researchers are homing in on a new target for malaria treatment, after developing a compound that blocks the action of a key 'gatekeeper' enzyme essential for malaria parasite survival.

The compound, called WEHI-916, is the first step toward a new class of antimalarial drugs that could cure and prevent malaria infections caused by all species of the parasite, including those resistant to existing drugs.

New compound blocks 'gatekeeper' enzyme to kill malaria

Approximately half of the world's population is at risk of contracting malaria each year, with more than 200 million people infected. Malaria kills up to 700,000 people each year, predominantly children under the age of five. Current antimalarial drugs are becoming less effective as the parasite develops resistance to the drugs, making the search for new targets that can kill all species of malaria critical.